Streetbeat News

Products Services

ALHC

Alignment Health Plan is expanding its provider network in Nevada through a new agreement with Intermountain Health, effective January 1, 2025. This expansion will provide members access to over 65 clinic locations, enhancing healthcare services in Clark and Washoe counties.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 3:03 pm

MLSS

Milestone Scientific Inc. (NYSE:MLSS) has announced the commercial rollout of its CompuFlo Epidural System at iHeal Pain Center, following successful procedures and a favorable Medicare price assignment. This marks a significant step in their commercial activities, supported by a strategic partnership with Axial Biologics.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 3:02 pm

CUPR

Cuprina Holdings (Cayman) Limited is set to IPO on NASDAQ under the ticker CUPR, with shares priced between $4.00 and $4.50. The company specializes in biomedical and biotechnology products for chronic wound management and the health and beauty sector.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 3:00 pm

MULN

Mullen Automotive's stock is trading lower despite its subsidiary, Bollinger Motors, completing its first delivery of the 2025 Bollinger B4 Chassis Cab, generating $800,000 in revenue. The company expects a significant revenue increase for the quarter ending September 30, 2024.

Portfolio Pulse from Nabaparna Bhattacharya

October 03, 2024 | 2:56 pm

SOBR

SOBR Safe shares are experiencing a decline following the company's announcement of expansion opportunities in India, Italy, and Australia.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 2:53 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides a detailed analysis of key stocks and ETFs, including SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, with specific price levels to watch for potential breakouts or reversals. The memo emphasizes the importance of monitoring these assets closely, especially with upcoming economic data releases and Fed speeches that could impact market sentiment.

Portfolio Pulse from RIPS

October 03, 2024 | 2:52 pm

BMY

The FDA has approved the use of nivolumab as a neoadjuvant and adjuvant treatment for resectable non-small cell lung cancer. This approval is significant for Bristol-Myers Squibb (BMY), the company behind nivolumab, as it expands the drug's market potential.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 2:52 pm

TSLA

Tesla Inc (NASDAQ:TSLA) reported a year-over-year increase in vehicle deliveries for Q3 2024, with 462,890 units delivered, marking a 6.4% rise. Production also increased by 9.1% year-over-year. Despite some estimates being missed, Tesla's growth trajectory continues, with a focus on launching a next-gen vehicle.

Portfolio Pulse from Chris Katje

October 03, 2024 | 2:51 pm

STZ

Constellation Brands executives have noted a shift in consumer behavior towards more value-oriented packs and channels as a strategy to manage spending. This trend was discussed during a conference call.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 2:50 pm

TOVX

Theriva Biologics' investigational drug SYN-004 shows safety in bone marrow transplant patients, with no adverse events related to the drug. The DSMC recommends proceeding to the next trial phase. TOVX stock rose 33.30% on the news.

Portfolio Pulse from Vandana Singh

October 03, 2024 | 2:45 pm